Meeting
2017 ASCO Annual Meeting
Synergism of gambogenic acid with bortezomib induce apoptosis of multiple myeloma.
Authors
Runzhe Chen
Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, China
Runzhe Chen , Hongming Zhang , Ping Liu , Xue Wu , Baoan Chen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8035)
DOI
10.1200/JCO.2017.35.15_suppl.8035
Abstract #
8035
Poster Bd #
361
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Effect of combination of proteasome inhibitor marizomib and immunomodulatory agent pomalidomide on synergistic cytotoxicity in multiple myeloma.
First Author: Dharminder Chauhan
Poster
2021 Genitourinary Cancers Symposium
In vitro and in vivo investigations of novel 1,4-napthoquinone sulphomethylene carbohydrate conjugates in prostate cancer.
First Author: Tobias Busenbender
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Low molecular weight heparin (LMWH) enhances immunotherapy (I) activity in pancreatic cancer cells.
First Author: Michalis Karamouzis
First Author: Allison Distler